Oak Associates’s Avanos Medical AVNS Stock Holding History

Oak Associates’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,300	Closed	-$475K	–	157
2018 Q1	$475K	Sell	10,300 -400	-4%	-$19K	0.03%	130
2017 Q4	$494K	Sell	10,700 -1,000	-9%	-$46K	0.04%	131
2017 Q3	$527K	Hold	11,700	–	–	0.04%	136
2017 Q2	$460K	Hold	11,700	–	–	0.03%	139
2017 Q1	$446K	Hold	11,700	–	–	0.04%	138
2016 Q4	$433K	Hold	11,700	–	–	0.04%	145
2016 Q3	$378K	Hold	11,700	–	–	0.04%	144
2016 Q2	$380K	Buy	+11,700	New	+$358K	0.05%	138

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Oak Associates's AVNS Position: Q2 2018 in Review

Oak Associates sold out of Avanos Medical (AVNS) in Q2 2018, closing a stake of 10,300 shares — an estimated $475K sold.

Oak Associates first reported a position in AVNS in Q2 2016 and held it in 8 quarters. The position peaked at $527K in Q3 2017. 321 funds tracked by Wall St. Rank hold AVNS as of Q2 2018.

Oak Associates reported no remaining Avanos Medical position as of Q2 2018 after selling out during the quarter.
Oak Associates sold 10,300 Avanos Medical shares in Q2 2018, an estimated $475K.
Oak Associates first reported a position in Avanos Medical in Q2 2016 and held it in 8 quarters.
Oak Associates's Avanos Medical position peaked at $527K in Q3 2017.
321 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2018.

Based on Oak Associates's 13F filing for Q2 2018, filed 14 Aug 2018.